Skip to main navigation Skip to search Skip to main content

A Randomized, Rater-blinded, Multicenter, Parallel-Group Study Comparing the Efficacy and Safety of Betaseron 250ug Subcutaneously Every Other Day with Avonex 30ug Intramuscularly Once per Week in Relapsing Remitting Multiple Sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date09/5/0306/6/07

Funding

  • Berlex Laboratories Inc: $103,068.69